FDANonrulemakingFDA-2018-D-1895

Who commented on this docket

Indications and Usage Section of Labeling for Human Prescription Drug and Biological Products -- Content and Format; Draft Guidance for Industry; Availability

2 organizations filed 2 public comments on Indications and Usage Section of Labeling for Human Prescription Drug and Biological Products -- Content and Format; Draft Guidance for Industry; Availability, at the Food and Drug Administration. The comment window closed 2881d ago.

Organizations
2
Comments
2
RIN
Comment window
closed 2881d ago

Commenters (2)

View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.